FDA Approves Alemtuzumab for Relapsing Forms of Multiple SclerosisByHCPLive StaffNovember 15th 2014The FDA has approved alemtuzumab (Lemtrada) for the treatment of patients with relapsing forms of multiple sclerosis.
FDA Approves sNDA for Oral Erectile Dysfunction TreatmentByHCPLive StaffSeptember 18th 2014The FDA has approved a supplemental new drug application for avanafil (Stendra) to treat erectile dysfunction in men.